Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Maynard Ryan D Create: Alert

All | News | Filings
Date FiledTypeDescription
06/08/2023 4 Maynard Ryan D (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Granted 51,955 options to buy @ $0
09/14/2022 4 Maynard Ryan D (CFO) has filed a Form 4 on Cara Therapeutics, Inc.
Txns: Granted 225,000 options to buy @ $10.75, valued at $2.4M
09/14/2022 3 Maynard Ryan D (CFO) has filed a Form 3 on Cara Therapeutics, Inc.
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2020 4 Maynard Ryan D (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Granted 35,000 options to buy @ $32.17, valued at $1.1M
06/11/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2018 4 Maynard Ryan D (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Granted 35,000 options to buy @ $14.45, valued at $505.8k
11/07/2017 4 Maynard Ryan D (EVP & CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC
Txns: Sold 100,000 shares @ $3.9, valued at $390k
Exercised 100,000 options to buy @ $2.14, valued at $214k
06/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
04/21/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
08/18/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
04/06/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
09/14/2012 4/A Maynard Ryan D (EVP & CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC
Txns: Sold 23,302 shares @ $10.6669, valued at $248.6k
Exercised 23,302 options to buy @ $6.49, valued at $151.2k
09/14/2012 4 Maynard Ryan D (EVP & CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC
Txns: Exercised 23,302 shares @ $6.49, valued at $151.2k
Sold 23,302 shares @ $10.6669, valued at $248.6k
Exercised 23,302 options to buy @ $6.49, valued at $151.2k
09/11/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
08/09/2012 4 Maynard Ryan D (EVP & CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC
Txns: Sold 700 shares @ $10.6, valued at $7.4k
Sold 100 shares @ $10.61, valued at $1.1k
Sold 600 shares @ $10.62, valued at $6.4k
Sold 300 shares @ $10.625, valued at $3.2k
Exercised 1,700 options to buy @ $6.49, valued at $11k
01/27/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
02/03/2011 4 Maynard Ryan D (EVP & CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC
Txns: Granted 65,000 options to buy @ $6.73, valued at $437.5k
06/01/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
01/25/2010 4 Maynard Ryan D (VP, CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC
Txns: Granted 85,000 options to buy @ $9.62, valued at $817.7k
03/31/2009 4 Maynard Ryan D (VP, CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy